N-Acetyltransferase 2 genotype, exfoliated urothelial cells and benzidine exposure

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 5, 2012, Pages 1966-1974

  Ma, Qing Wen ^a   Lin, Guo Fang ^a   Chen, Ji Gang ^b   Guo, Wei Chao ^a   Qin, Yi Qiu ^b   Golka, Klaus ^c   Shen, Jian Hua ^a  

^a INSTITUTE OF PLANT PHYSIOLOGY AND ECOLOGY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c TU DORTMUND UNIVERSITY   (Germany)

Author keywords

Benzidine; Bladder cancer; Chinese; NAcetyltransferase 2; Occupational exposure; Papanicolaou's grading; Polymorphism

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; BENZIDINE; BENZIDINE DERIVATIVE; NAT2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER RISK; CELL TYPE; CONTROLLED STUDY; DNA EXTRACTION; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; EXFOLIATED UROTHELIAL CELL; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PAPANICOLAOU TEST; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSITIONAL CELL CARCINOMA; URINALYSIS; UROTHELIUM; COHORT ANALYSIS; DRUG EFFECT; ENZYMOLOGY; GENETICS; POLYMERASE CHAIN REACTION;

ARYLAMINE N-ACETYLTRANSFERASE; BENZIDINES; COHORT STUDIES; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; UROTHELIUM;

EID: 84860847551     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. D.W. Hein, M.A. Doll, T.D. Rustan, K. Gray, Y. Feng, R.J. Ferguson, D.M. Grant: Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 14, 1633 -1638 (1993) (Pubitemid 23249371)
2. D.A. Evans: N-Acetyltransferase. In: W. Kalow, ed.: Pharmacogenetics of drug metabolism. Pergamon Press NY 95-178 (1992)
3. M. Blum, A. Demierre, D.M. Grant, H. Heim, U.A. Meyer: Molecular mechanism of slow acetylation of drug and carcinogens in humans. Proc Natl Acad Sci U S A 88, 5237-5241 (1991) (Pubitemid 21914719)
4. K.P. Vatsis, W.W. Weber, D.A. Bell, J.U. Dupret, D.A.P. Evans, D.M. Grant, D.W. Hein, H.J. Lin, U.A. Meyer, M.V. Relling, E. Sim, T. Suzuki, Y. Yamazoe: Nomenclature for N-acetyltransferases. Pharmacogenetics 5, 1-17 (1995) http://dx.doi.org/10.1097/00008571-199502000-00001
5. D.W. Hein, S. Boukouvala, D.M. Grant, R.F. Minchin, E. Sim: Changes in consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenet Genomics 18, 367-368 (2008) (Pubitemid 351367530)
6. Y.K. Ozbek, T. Ozturk, B.M. Tuzuner, Z. Calay, S. Ilvan, F.M. Seyhan, H.I. Kisakesen, O. Ozturk, T. Isbir: Combined effect of CYP1B1 codon 432 polymorphism and Nacetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population. Anticancer Res 30, 2885-2889 (2010)
7. L.M. Dong, J.D. Potter, E. White, C.M. Ulrich, L.R. Cardon, U. Peters: Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299, 2423-2436 (2008) (Pubitemid 351749241)
8. A. Khedhaier, E. Hassen, N. Bouaouina, S. Gabbouj, S.B. Ahmed, L. Chouchane: Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer 8, 109 (2008)
9. W. Zhou, G. Liu, S.W. Thurston, L.L. Xu, D.P. Miller, J.C. Wain, T.J. Lynch, L. Su, D.C. Christiani: Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol Biomarkers Prev 11, 15-21 (2002) (Pubitemid 34118308)
10. M. Gajecka, M. Rydzanicz, R. Jakula-Sztul, M. Kujawski, W. Szyfter, K. Szyfter: CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574, 112-123 (2005) (Pubitemid 40725973)
11. H.L. Chiou, W.F. Wu, W.P. Chien, Y.W. Cheng, R.H. Wong, C.Y. Chen, T.S. Lin, H. Lee: NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan. Cancer Lett 223, 93-101 (2005) (Pubitemid 40693713)
12. S.H. Hong, J.W. Kim, H.G. Kim, I.K. Park, J.W. Ryoo, C.H. Lee, Y.K. Sohn, J.Y. Lee: Glutathione Stransferases (GSTM1, GSTT1 and GSTP1) and Nacetyltransferase 2 polymorphisms and the risk of gastric cancer. J Prev Med Pub Health 39, 135-140 (2006)
13. C. Lilla, E. Vorla-Tebit, A. Risch, B. Jager, M. Hoffmeiter, H. Brenner, J. Chang-Claude: Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 15, 99-107 (2006)
14. L. Rocha, C. Garcia, A. Mendonca, J.P. Gil, D.T. Bishop, M.C. Lechner: N-Acetyltransferase (NAT2) genotype and susceptibility to sporadic Alzheimer's disease. Pharmacogenetics 9, 9-15 (1999) http://dx.doi.org/10.1097/00008571- 199902000-00002 (Pubitemid 29176718)
15. W.C. Guo, G.F. Lin., Y.L. Za, K.J. Lou, Q.W. Ma, J.H. Shen: N-Acetyltransferase 2 gene polymorphism in a group of senile dementia patients in Shanghai suburb. Acta Pharmacol Sin 25, 1112-1127 (2004a)
16. K. Golka, V. Prior, M. Blaszkewicz, H.M. Bolt: The enhanced bladder cancer susceptibility of NAT2 slow acetyltaor towards aromatic amines: a review considering ethnic differences. Toxicol Lett 128, 229-241 (2002) (Pubitemid 34183465)
17. W. Weistenhöfer, M. Blaszkewicz, H.M. Bolt, K. Golka: N-Acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany. J Toxicol Environ Health A 71, 906-910 (2008) (Pubitemid 352000701)
18. D.K.Song, D.L. Xing, L.R. Zhang, Z.X. Li, J. Liu, B.P. Qiao: Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detect Prev 32,416-423 (2009)
19. H. Tsukino, Y. Kuroda, H, Nakao, H. Imai, H. Inatomi, Y. Osada, T. Katoh: Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. J Cancer Res Clin Oncol 130, 99-106 (2004) (Pubitemid 38316673)
20. W.J. Kim, H.L. Lee, S.C. Lee, Y.T. Kim, H. Kim: Polymorphisms of N-acetyltransferase 2, glutathione Stransferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol 164, 209-213 (2000) (Pubitemid 30434302)
21. Q.W. Ma, G.F. Lin, J.G. Chen, K. Golka, C.Q. Xiang, D.R. Lu, W.C. Guo, J.H. Shen: Polymorphism of Nacetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups. Biomed Environ Sci 17, 291-298 (2004) (Pubitemid 39486795)
22. International Agency for Research on Cancer (IARC): Monographs on the Evaluation of the Carcinogenic Risk to Humans. Suppl. 7 Overall Evaluations of Carcinogenicity, An Updating of IARC Monographs Vol. 1-42 Lyon, France (1987)
23. G.F. Lin, Q.W. Ma, J.G. Chen, J.H. Shen, C.Q. Xiang, K. Golka, D.S. Zhang: Dependence of Papanicolaou gradings of exfoliated urothelial cells upon GSTM1 and GSTT1 polymorphism in benzidine-exposed workers of the Shanghai dye industry. Arch Toxicol 75, 544-548 (2001) (Pubitemid 33044113)
24. X.Y. You, J.G. Chen, Y.F Yao: A retrospective prospective investigation on bladder cancer in the workers exposed to benzidine in Shanghai dyestuff industry. Tumor 3, 197-201(1983) (In Chinese)
25. Q.W. Ma, G.F. Lin, D.R. Lu, C.Q. Xiang, K. Golka, F. Geller, J.G. Chen, J.H. Shen: GSTP1 A1578G (Ile105Val) polymorphism in benzidine-exposed workers: an association with cytological grading of exfoliated urothelial cell. Pharmacogenetics 13, 409-415 (2003) (Pubitemid 36900736)
26. W.C. Guo, G.F. Lin, J.G. Chen, K. Golka, J.H. Shen: Polymorphism in the N-acetyltransferase 1 alleles NAT1*10 and NAT1*14A and cytological gradings of exfoliated urothelial cells in benzidine-exposed Chinese workers: discussion of ethnic differences. Arch Toxicol 78, 425-429 (2004b) (Pubitemid 39222678)
27. G.F. Lin, W.C. Guo, J.G. Chen, Y.Q. Qin, K. Golka, C.Q. Xiang, Q.W. Ma, J.H. Shen: The association of UDPglucuronosyltransferase 2B7 C802T (His 268Tyr) polymorphism with bladder cancer in benzidine exposed workers in China. Toxicol Sci 85, 502-506 (2005) (Pubitemid 40614279)
28. R.A. Cartwright, R.W. Gasman, H.J. Rogers, R.A. Ahmad, D. Braham-Hall, E. Higgins, M. Kahn: A role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 320(8303), 842-846 (1982) http://dx.doi.org/10.1016/S0140-6736(82)90810-8 (Pubitemid 12018550)
29. J. Lewalter, L.W. Mischke: Empfehlungen zur arbeitsmedizinischen Prävention expositions- und dispositionsbedingter Arbeitsstoff- Beanspruchungen. Verh Dt Ges Arbeitsmed 31, 135-139 (1991) (in German)
30. R.B. Hayes, W.F. Bi, N. Rothman, F. Broly, N. Caporaso, P.W. Feng, X.J. You, S.N. Yin, R.L. Woosley, U.A. Meyer: N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 14, 675-678 (1993) (Pubitemid 23150001)
31. T. Carreon, T. Ruder, P.A. Schulte, R.B. Hayes, N. Rothman, M. Waters, D.J. Grant, R. Boissy, D.A. Bell, F.F. Kadlubar, G.P. Hemstreet 3rd, S. Yin, G.K. LeMasters: NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. Int J Cancer 118, 161-168 (2006) (Pubitemid 41681593)
32. M. Sone: Determination of the N-acetyltransferase phenotype in urothelial cancer patients and healthy controls. Hinyokika Kiyo 32, 1085-1092 (1986) (in Japanese)
33. G.N. Papanicolaou: A new procedure for staining vaginal smears. Science 95, 438-439 (1942)
34. G.N. Papanicolaou, V.F. Marshall: Urine sediment smears: a diagnostic procedure in cancer of the urinary tract. Science 101, 519-520 (1945)
35. I. Cascorbi, J. Brockmoeller, P.M. Mrozikiewicz, S. Bauer, R. Loddenkemper, I. Roots: Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 56, 3961-3966 (1996) (Pubitemid 26284745)
36. T.V. Zenser, V.M. Lakshmi, T.D. Rustan, M.A. Doll, A.C Deitz, B.B. Davis, D.W Hein: Human N-acetylation of benzidine: role of NAT1 and NAT2. Cancer Res 56, 3941-3947 (1996) (Pubitemid 26284742)
37. G.H. Degen, J.H. Schlattjahn, S. Mähler, W. Föllmann, K. Golka: Comparative metabolic activation of benzidine and Nacetylbenzidine by prostataglandin H synthase. Toxicol Lett 151, 135-142 (2004) (Pubitemid 38739035)
38. H.G. Neumann: Aromatic amines: mechanisms of carcinogenesis and implications for risk assessment. Front Biosci 15, 1119-1130 (2010) http://dx.doi.org/10.2741/3665
39. S.R. Babu, V.M. Lakshmi, T.V. Zenser, B.B Davis: Glucuronidation of N-acetylbenzidine by human liver. Drug Metab Dispos 22, 922-927 (1994) (Pubitemid 24377369)
40. S.R. Babu, V.M. Lakshmi, F.F. Hsu, T.V. Zenser, B.B. Davis: Glucuronidation of N-hydroxy metabolites of Nacetylbenzidine. Carcinogenesis 16, 3069-3074 (1995)
41. V. M. Lakshmi, T. V. Zenser, B.B. Davis: Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N, N'- diacetylbenzidine. Drug Metab Dispos 25, 481-488 (1997) (Pubitemid 27209373)
42. T.J. Flammang, Y. Yamazoe, R.W. Benson, D.W. Roberts, D.W. Potter, D.Z. Chu, N.P. Lang, F.F. Kadlubar: Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Res 49, 1977-1982 (1989) (Pubitemid 19106500)
43. K. Golka, V. Prior, M. Blaszkewicz, I. Cascorbi, W. Schops, G. Kierfeld, I. Roots, H.M. Bolt: Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany, Scand J Work Environ Health 22, 332-338 (1996) (Pubitemid 26372136)
44. K. Golka, T. Reckwitz, M. Kempkes, I. Cascorbi, M. Blaszkewicz, S.E. Reich, I. Roots, J. Soekeland, H. Schulze, H.M. Bolt: N-Acetyltransferase 2 (NAT2) and glutathione Stransferase μ (GSTM1) in bladder cancer patients in a highly industrialized area. Int J Occup Environ Health 3, 105-110 (1997) (Pubitemid 127816931)
45. K. Golka, M. Blaszkewicz, M. Samimi, H.M. Bolt, S. Selinski: Reconstruction of N-acetyltransferase 2 haplotypes using PHASE. Arch Toxicol 82, 265-270 (2008) (Pubitemid 351661652)
46. J.A. Agúndez, K. Golka, C. Martínez, S. Selinski, M. Blaszkewicz, E. García-Martin: Unravelling ambigous NAT2 genotyping data. Clin Chem 54, 1390-1396 (2008)